View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Dashboards
  2. Surveys
June 1, 2021updated 02 Jun 2021 9:45am

Clinical trial sponsors warm up to using decentralised clinical trials

Clinical trial sponsors from Pharma/Biotech and Government/Academic Institutes earlier used decentralised clinical trials (DCTs) the least - under 20%.

Because of COVID-19, over half of these respondents have warmed up to using DCTs.

GlobalData carried out a survey from 04 to 20 June 2020 to know if Covid-19 was the reason for using DCTs for the first time.

The survey found that 57% of Government/Academic Institutes, and 54% Pharma/Biotech cited Covid as the reason for use of DCTs.

Clinical trial sponsors warm up to using DCTsIs COVID-19 the Reason You Will Begin Using Decentralised Trials for the First time?

It also found that 49% of other contract service providers, who include CMOs, bioanalysis, training, consulting, software and digital solution providers, and 36% of clinical and investigator sites cited COVID-19 as the reason for DCTs use.

Among CROs, only 29% cited COVID-19 as the reason for shifting to DCTs. However, this group was one of the biggest pre-pandemic adopters.

Although respondents overwhelmingly stated that the transition toward DCTs was already planned, COVID-19 strengthened the interest from sponsors and paced up the adoption.

In addition to COVID-19, respondents listed out patient centricity, innovation in clinical trial environment, patient accessibility, shift to work remotely, as the other reason for embracing DCTs.

Some respondents were unsure about DCTs due to implementation timeframe,  minimal improvement from COVID-19 impact, legal issues, and the requirement to decide on a trial by trial basis.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology